title: Genetic determinants of coxsackievirus B3 pathogenesis.
abstract: The development of high throughput genomic and bioinformatic analysis tools, coupled with established molecular techniques, has allowed new insights into the pathogenesis of infectious diseases. In humans, coxasackievirus B3 (CVB3) is the primary etiological agent of viral myocarditis, an inflammatory disease process involving the heart muscle. Early host cellular survival and apoptotic mechanisms during viral infections, as well as immune events, affect myocarditis progression and outcome. Therefore, our laboratory has been keenly interested in infectomics, defined here as the transcriptional events of both virus and host. We first elucidated up- or downregulated transcriptional activities in CVB3-infected hearts by mRNA differential display. Further characterization of these regulated genes including Nip21, IP10, and IGTPase, and study of their role in CVB3-infection are underway. In further dissection of the stages of myocarditis-peak viremia, inflammatory infiltration and tissue repair-we used cDNA microarrays to probe differential gene expression in the myocardium following virus infection. Following virus infection, there are global decreases in metabolic and mitochondrial genes, increases in signaling genes and distinctive patterns in other functional groups. To establish early gene expression profiles in infected cells by themselves, we also used oligonucleotide arrays in an in vitro model of CVB3 infection. Notably, we have found increased expression of transcription factors c-fos and c-jun down-stream of extracellular signal-related kinase, a pathway which is crucial for virus replication and pathogenesis. Our investigations based on gene profiling following CVB3 infection have thus far been fruitful in providing new experimental leads. High throughput genetic analysis has allowed us to simultaneously try on greater than 12,000 potential genetic "glass slippers." Our in vitro experimental plan has enabled us to chart prominent patterns of gene expression, analyzed by novel bioinformatic approaches, and to separate varied and potentially significant gene expression events.
authors.affiliation: UBC McDonald Research Laboratories/The iCAPTUR E Center, Department of Pathology and Laboratory Medicine, St. Paul's Hospital/Providence Health Care-University of British Columbia, Canada. bmcmanus@mrl.ubc.ca
authors.forename: Bruce M
authors.initials: BM
authors.lastname: McManus
authors.forename: Bobby
authors.initials: B
authors.lastname: Yanagawa
authors.forename: Nana
authors.initials: N
authors.lastname: Rezai
authors.forename: Honglin
authors.initials: H
authors.lastname: Luo
authors.forename: Lydia
authors.initials: L
authors.lastname: Taylor
authors.forename: Mary
authors.initials: M
authors.lastname: Zhang
authors.forename: Jane
authors.initials: J
authors.lastname: Yuan
authors.forename: Jonathan
authors.initials: J
authors.lastname: Buckley
authors.forename: Timothy
authors.initials: T
authors.lastname: Triche
authors.forename: George
authors.initials: G
authors.lastname: Schreiner
authors.forename: Decheng
authors.initials: D
authors.lastname: Yang
mesh_terms: D019295:Computational Biology; D003384:Coxsackievirus Infections / Q000209:etiology* / Q000235:genetics*; D029822:Enterovirus B, Human / Q000235:genetics* / Q000472:pathogenicity*; D020869:Gene Expression Profiling; D016762:Genes, fos; D016758:Genes, jun; D023281:Genomics; D006367:HeLa Cells; D006801:Humans; D009205:Myocarditis / Q000209:etiology / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D014774:Virulence / Q000235:genetics